v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Total revenues $ 86 $ 202 $ 570 $ 501
Operating expenses:        
Research and development 817 6,124 19,237 30,946
General and administrative 3,085 3,275 11,082 13,192
Total operating expenses 3,902 9,399 30,319 44,138
Operating loss (3,816) (9,197) (29,749) (43,637)
Other income, net 231 594 3,017 3,834
Loss from continuing operations before income taxes (3,585) (8,603) (26,732) (39,803)
Income tax expense 0 0 4 4
Loss from continuing operations (3,585) (8,603) (26,736) (39,807)
Loss from discontinued operations, net of income taxes 0 (8) 253 (27)
Net loss $ (3,585) $ (8,611) $ (26,483) $ (39,834)
Loss per share from continuing operations, basic (in dollars per share) $ (0.08) $ (0.2) $ (0.63) $ (0.93)
Loss per share from continuing operations, diluted (in dollars per share) (0.08) (0.2) (0.63) (0.93)
Loss per share from discontinued operations, basic (in dollars per share) 0 0 0.01 0
Loss per share from discontinued operations, diluted (in dollars per share) 0 0 0.01 0
Loss per share, basic (in dollars per share) (0.08) (0.2) (0.62) (0.93)
Loss per share, diluted (in dollars per share) $ (0.08) $ (0.2) $ (0.62) $ (0.93)
Weighted average shares outstanding - basic (in shares) 42,768 42,673 42,768,000 42,589,000
Weighted average shares outstanding - diluted (in shares) 42,768 42,673 42,768,000 42,589,000
Other comprehensive loss:        
Unrealized losses on marketable securities, net of tax of $0 $ (2) $ (20) $ (18) $ (6)
Total other comprehensive loss (2) (20) (18) (6)
Comprehensive loss $ (3,587) $ (8,631) $ (26,501) $ (39,840)